Relationship between interleukin-5 production and variations in eosinophil counts during HIV infection in West Africa: Influence of Mycobacterium tuberculosis infection

Scandinavian Journal of Immunology

Volumn 49, Issue 2, 1999, Pages 203-209

  Diagbouga, Serge ^c   Aldebert, D ^a   Fumoux, F ^c   Capron, M ^a   Ledru, E ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b INSTITUT PASTEUR   (France)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 5; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE;

ADULT; AFRICA; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; STAGING; TUBERCULOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; AFRICA SOUTH OF THE SAHARA; BIOLOGY; BURKINA FASO; DEVELOPING COUNTRIES; DISEASES; FRENCH SPEAKING AFRICA; HIV INFECTIONS; IMMUNITY; IMMUNOLOGIC FACTORS; INFECTIONS; PHYSIOLOGY; RESEARCH REPORT; TUBERCULOSIS; VIRAL DISEASES; WESTERN AFRICA;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; BURKINA FASO; CD4-POSITIVE T-LYMPHOCYTES; CROSS-SECTIONAL STUDIES; EOSINOPHILS; FEMALE; HIV-1; HUMANS; INTERLEUKIN-5; LEUKOCYTE COUNT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE COUNT; MALE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0033051451     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00467.x     Document Type: Article

References (47)

1. Sanderson CJ. Interleukin-5, eosinophils, and disease. Blood 1992;79:3101-9.
2. Capron M, Desreumaux P, Soussi Goussi A, Lamkhioued B, Capron A. L'éosinophile, bénéfique ou néfaste: une cellule à part entière dans la réponse immunitaire. C R Soc Biol 1994;188:39-46.
3. Desreumaux P, Capron M. Eosinophils in allergic reactions. Curr Opin Immunol 1996;8:790-5.
4. Harris PJ. Eosinophils and AIDS. Medical Hypotheses 1994;43:75-6.
5. Lucey DR, Dorsky DI, Nicholson-Weller A, Weller PF. Human eosinophils express CD4 protein and bind human immunodeficiency virus J gpl 20. J Exp Med 1989;169:327-32.
6. Combadiere C, Ahuja SK, Murphy PM. Cloning and functional expression of a human eosinophil CC chemokine receptor. J Biol Chem 1995;270:16491-4.
7. Doranz BJ, Rucker J, Yi Y et al. A dual-tropic primary HIV-1 isolate that uses fusin and the β-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 1996;85:1149-58.
8. Freedman AR, Gibson FM, Fleming SC, Spry CJ, Griffin GE. Human immunodeficiency virus infection of eosinophils in human bone marrow cultures. J Exp Med 1991;174:1661-4.
9. Ledru E, Diagbouga S, Tranchot-Diallo J et al. Eosinophils: a putative marker of immunodepression in HIV-infected African patients with tuberculosis? Trans R Soc Trop Med Hyg 1994;88: 117-8.
10. Weller PF, Marshall WL, Lucey DR, Rand HT, Dvorak AM, Finberg RW. Infection, apoptosis and killing of mature human eosinophils by human immunodeficiency virus-I. Am J Respir Cell Mol Biol 1995;13:610-20.
11. Clerici M, Shearer GM. A TH1→TH2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-10.
12. Yamaguchi Y, Suda T, Suda J et al. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43-56.
13. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in Sub-Saharan Africa. JAMA 1992;268:1581-7.
14. Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mortal Wkly Rep 1992;41:1-19.
15. World Health Organization. Acquired immunodeficiency syndrome (AIDS). Proposed WHO criteria for interpreting results from Western blot assays for HIV-1, HIV-2 and HTLV-I/HTLV-II. Wkly Epidemiol Record 1990;65:281-3.
16. Schandene L, Aloson-Vega C, Willems F et al. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J Immunol 1994;152:4368-74.
17. Beck JS, Potts RC, Kardjito T, Grange JM. T4 lymphopenia in patients with active pulmonary tuberculosis. Clin Exp Immunol 1985;60:49-54.
18. Ray D, Abel R. Hypereosinophilia in association with pulmonary tuberculosis in a rural population in south India. Indian J Med Res 1994;100:219-22.
19. Castro GA, Esaguy N, Macedo PM, Aguas AP, Silva MT. Live but not heat-killed mycobacteria cause rapid chemotaxis of large numbers of eosinophils in vivo and are ingested by the attracted granulocytes. Infect Immun 1991;59:3009-14.
20. Brown AE, Holzer TJ, Andersen BR. Capacity of human neutrophils to kill Mycobacterium tuberculosis. J Infect Dis 1987;156:985-9.
21. Rumke CL. Imprecision of ratio-derived differential leucocyte counts. Blood Cells 1985;11:137-40.
22. Sanchez-Borges M, Orozco A, Dibiagio E, Tami I, Suarez-Chacon P. Eosinophilia in early-stage in human immunodeficiency virus infection. J Allergy Clin Immunol 1993;92:494-5.
23. Klebanoff SJ, Coombs RW. Virucidal effect of stimulated eosinophils on human immunodeficiency virus type I. AIDS Res Hum Retrovir 1996;12:25-9.
24. Lim KG, Wan HC, Bozza PT et al. Human eosinophils elaborate the lymphocyte chemoattractants IL-I6 (lymphocyte chemoattractant factor) and RANTES. J Immunol 1996;156:2566-70.
25. Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis 1996;174:615-8.
26. Casterino-de-Araujo A. HIV-1 infection and eosinophilia. Immunol Today 1994;15:498-9.
27. Bentwich Z, Kalinkovich A, Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995;16:187-91.
28. Barnes PF, Lu S, Abrams JS, Wang E, Yamamura M, Modlin RL. Cytokine production at the site of disease in human tuberculosis. Infect Immun 1993;61:3482-9.
29. Meyaard L, Hovenkamp E, Keet IPM et al. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J Immunol 1996;157:2712-8.
30. Ledru E, Lecoeur H, Garcia S, Debord T, Gougeon ML. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets. Correlation with Bcl-2 expression and consequences for AIDS pathogenesis. J Immunol 1998;160:3194-206.
31. Ledru E, Diagbouga S, Meda N et al. A proposal for basic management of HIV disease in West Africa-use of clinical staging and haemogram data. Int J STD AIDS 1998;9:463-70.
32. Mukadi Y, Perriens JH, St Louis ME et al. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Lancet 1993;342:143-6.
33. Peng X, Kasran A, Bullens D, Ceuppens JL. Ligation of CD2 provides a strong helper signal for the production of the type 2 cytokines interleukin-4 and -5 by memory T cells. Cell Immunol 1997;181:76-85.
34. Lamkhioued B, Aldebert D, Soussi-Gounni A et al. Synthesis of cytokines by eosinophils and their regulation. Int Arch Allergy Immunol 1995;107:122-3.
35. Dubucquoi S, Desreumaux P, Janin A et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med 1994;179:703-8.
36. Lecoeur H, Gougeon ML. Comparative analysis of flow cytometric methods for apoptosis quantitation in murine thymocytes and human peripheral lymphocytes from controls and HIV-infected persons. Evidence for interference by granulocytes and erythrocytes. J Immunol Methods 1996;198:87-99.
37. Zhang M, Lin Y, Iyer DV, Gong J, Abrams JS, Barnes PF. T-cell cytokine responses in human infection with Mycobacterium tuberculosis. Infect Immun 1995;63:3231-4.
38. Del Prete GF, De Carli M, Mastromauro C et al. Purified protein derivative of M. tuberculosis and excretory-secretory antigen (s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J Clin Invest 1991;88:346-50.
39. Pearlman E, Kazura JW, Hazlett FE, Boom WH. Modulation of murine cytokine response to mycobacterial antigens by helminth-induced T helper 2 cell responses. J Immunol 1993;151:4857-64.
40. Castro AG, Silva RA, Minoprio P, Appelberg R. In vivo evidence for a non-T cell origin of interleukin-5. Scand J Immunol 1995;41:288-92.
41. Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of tuberculin skin test in HIV-1 seropositive patients. Int J Tuberc Lung Dis 1998;2:317-23.
42. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990;65:6-24.
43. Shalit M, Sekhsaria S, Malech HL. Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL-5 and other growth factors. Cell Immunol 1995;160:50-7.
44. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, Celestin J, Leder P, Luster AD. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nature Med 1996;2:449-56.
45. Collins PD, Marleau S, Griffiths-Johnson DA, Jose PJ, Williams TJ. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med 1995;182:1169-74.
46. Mould AW, Matthaei KI, Young IG, Foster PS. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest 1997;99:1064-71.
47. Menezesdelimajunior O, Werneckbarroso E, Cordeiro RSB, Henriques MDMO. Effects of inhibitors of inflammatory mediators and cytokines on eosinophil and neutrophil accumulation induced by Mycobacterium boris bacillus Calmette-Guérin in mouse pleurisy. J Leukocyte Biol 1997;62:778-85.